Literature DB >> 15235885

Phlebotomy: a promising treatment for chronic hepatitis C.

Naoki Tanaka, Kendo Kiyosawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15235885     DOI： 10.1007/s00535-004-1372-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  3 in total

1.  Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahiro Yamaura; Michiharu Komatsu; Eiji Tanaka; Kendo Kiyosawa
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

2.  Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular glycyrrhizin injections.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahiro Yamaura; Michiharu Komatsu; Takahide Yokoyama; Shinji Okaniwa; Tadanobu Nagaya; Kaname Yoshizawa; Kendo Kiyosawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2009-04-08       Impact factor: 7.527

Review 3.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.